Ancora Heart Inc., a privately-held medical device company, on Wednesday said that its investigational non-surgical heart failure therapy AccuCinch Ventricular Repair System for the treatment of systolic heart failure showed positive results in its study dubbed CorCinch FMR.
from RTT - Biotech https://ift.tt/2nsXub5
via IFTTT
No comments:
Post a Comment